Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $335.05 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, LLC | $124.52 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $121.22 | 1 | $0 (2022) |
| ATRICURE, INC. | $89.31 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.31 | 1 | ATRICURE, INC. ($89.31) |
| 2022 | $121.22 | 1 | AstraZeneca Pharmaceuticals LP ($121.22) |
| 2020 | $124.52 | 1 | PORTOLA PHARMACEUTICALS, LLC ($124.52) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | ATRICURE, INC. | ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $89.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/06/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $121.22 | General |
| Category: Rare Disease | ||||||
| 06/25/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 17 | $2,615 | $845.70 |
| 2022 | 4 | 106 | 107 | $37,538 | $8,162 |
| 2021 | 11 | 276 | 283 | $66,072 | $18,007 |
| 2020 | 5 | 101 | 112 | $8,152 | $3,054 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 17 | 17 | $2,615 | $845.70 | 32.3% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 27 | 27 | $18,392 | $3,525 | 19.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 31 | 31 | $11,776 | $2,631 | 22.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 33 | 34 | $5,743 | $1,606 | 28.0% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 15 | 15 | $1,628 | $399.95 | 24.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 41 | 41 | $28,266 | $6,116 | 21.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 42 | 42 | $15,800 | $4,070 | 25.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 46 | 48 | $9,272 | $2,767 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 36 | $4,968 | $2,391 | 48.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 14 | $2,772 | $1,506 | 54.3% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 11 | 11 | $1,131 | $305.37 | 27.0% |
| 84484 | Troponin (protein) analysis, quantitative | Office | 2021 | 18 | 19 | $1,653 | $236.93 | 14.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 22 | 22 | $682.00 | $232.32 | 34.1% |
| 82553 | Creatine kinase (cardiac enzyme) level, mb fraction only | Office | 2021 | 18 | 19 | $741.00 | $219.45 | 29.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 18 | 19 | $703.00 | $125.02 | 17.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 12 | 12 | $84.00 | $38.04 | 45.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 33 | $4,426 | $1,905 | 43.0% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 15 | 17 | $1,904 | $436.90 | 22.9% |
| 84484 | Troponin (protein) analysis | Office | 2020 | 18 | 20 | $360.00 | $249.40 | 69.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 20 | 22 | $682.00 | $232.32 | 34.1% |
| 82553 | Creatine kinase (cardiac enzyme) level | Office | 2020 | 18 | 20 | $780.00 | $231.00 | 29.6% |
About Dr. Sasha Reid, DO
Dr. Sasha Reid, DO is a Emergency Medicine healthcare provider based in Wickenburg, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1841780079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sasha Reid, DO has received a total of $335.05 in payments from pharmaceutical and medical device companies, with $89.31 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($335.05).
As a Medicare-enrolled provider, Reid has provided services to 500 Medicare beneficiaries, totaling 519 services with total Medicare billing of $30,069. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Wickenburg, AZ
- Active Since 05/14/2018
- Last Updated 05/23/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1841780079
Products in Payments
- ANDEXXA (Biological) $245.74
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM (Device) $89.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.